Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5289787
Max Phase: Preclinical
Molecular Formula: C22H28N4O10
Molecular Weight: 508.48
Associated Items:
ID: ALA5289787
Max Phase: Preclinical
Molecular Formula: C22H28N4O10
Molecular Weight: 508.48
Associated Items:
Canonical SMILES: C[C@@H]([C@H](N)C(=O)N[C@H](C(=O)O)[C@@H]1C[C@@H](O)[C@@H](O)[C@H](n2ccc(=O)[nH]c2=O)O1)[C@H](O)c1ccc(O)cc1
Standard InChI: InChI=1S/C22H28N4O10/c1-9(17(30)10-2-4-11(27)5-3-10)15(23)19(32)25-16(21(33)34)13-8-12(28)18(31)20(36-13)26-7-6-14(29)24-22(26)35/h2-7,9,12-13,15-18,20,27-28,30-31H,8,23H2,1H3,(H,25,32)(H,33,34)(H,24,29,35)/t9-,12+,13-,15-,16-,17-,18+,20+/m0/s1
Standard InChI Key: VSIBSKJVEGOXHC-SQLXPRKWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 508.48 | Molecular Weight (Monoisotopic): 508.1805 | AlogP: -2.48 | #Rotatable Bonds: 8 |
Polar Surface Area: 237.43 | Molecular Species: ACID | HBA: 11 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.48 | CX Basic pKa: 7.95 | CX LogP: -4.60 | CX LogD: -4.70 |
Aromatic Rings: 2 | Heavy Atoms: 36 | QED Weighted: 0.19 | Np Likeness Score: 1.05 |
1. Serpi M, Ferrari V, Pertusati F.. (2016) Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?, 59 (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325] |
Source(1):